Superworth

Precigen EV/EBIT PGEN

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2020.

Today, Oct 23, 2026
n/m
a quarter missing
7-year median
15.7×
7-year range
6.8× to 486×
Peer median
10.5×

Precigen's EV/EBIT can't be checked today: its operating income for Q2 FY26, the quarter to Jun 30, 2026, is missing from our data, so the twelve months it rests on can't be added up.

On the days it had one over the last 7 years, its median was 15.7×, from 6.8× in May 2020 to 486× in Mar 2026.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far30.8×30.4×486×
2025n/m a value too high to mean anything
2024n/m a value too high to mean anything
2023n/m a value too high to mean anything
2022n/m a value too high to mean anything
202115.7×14.5×17.2×
202018.8×6.8×18.8×

Against its peers

Companies in Drug Manufacturers - General nearest Precigen's size, closest first, today.

CompanyEV/EBIT
PGENPrecigenn/m
PBHPrestige Consumer Healthcare14.5×
HRMYHarmony Biosciences6.9×
NRIXNurix Therapeutics7.1×
ANIPANI Pharmaceuticals10.5×
PAHCPhibro Animal Health11.7×
ANABAnaptysbion/m
PCRXPacira BioSciences7.6×
OGNOrganon9.5×
LQDALiquidia21.7×
ARQTArcutis Biotherapeutics111×
Peer median10.5×

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Precigen

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.